image
Healthcare - Biotechnology - NASDAQ - CA
$ 1.17
-3.31 %
$ 5.13 M
Market Cap
-0.69
P/E
BALANCE SHEET
7.26 M ASSETS
21.87%
4.15 M LIABILITIES
-16.54%
3.11 M EQUITY
127.85%
BALANCE SHEET DECOMPOSITION
Balance Sheet Clearmind Medicine Inc.
image
Current Assets 7.09 M
Cash & Short-Term Investments 6.86 M
Receivables 181 K
Other Current Assets 44.2 K
Non-Current Assets 167 K
Long-Term Investments 0
PP&E 51.7 K
Other Non-Current Assets 116 K
Current Liabilities 4.13 M
Accounts Payable 526 K
Short-Term Debt 36.7 K
Other Current Liabilities 3.57 M
Non-Current Liabilities 16.4 K
Long-Term Debt 16.4 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Oct-2024 Oct-2023 Oct-2022 Oct-2021 Oct-2020 Oct-2019 Oct-2018 Oct-2017
ASSETS
Cash & Cash Equivalents 6.6 5.4 0.2 4.6 0.3 688 73.7 K 0.1
Short Term Investments 0.3 62.3 K 0.3 0 0 0 0 0
Receivables 0.2 0.2 0 0.1 0 3.1 K 8.45 K 289
Inventory 0 40.7 K 0 0 3.13 K 3.1 K 0 0
Other Current Assets 44.2 K 81.1 K 0.1 0.3 3.13 K 3.1 K 0 8.25 K
Total Current Assets 7.1 5.8 0.6 4.9 0.3 3.79 K 82.1 K 0.1
PP&E 51.7 K 1.25 K 66.4 K 20.6 K 0.2 0.2 0.2 18.4 K
Intangible Assets 0 0.1 0.2 0.2 0 0 0 0
Goodwill 0 873 0 0 0 0 0 0
Long Term Investments 0 23.8 K 20 K 20 K 0 0 0 0
Other Long Term Assets 7.19 K 14.3 K 0.3 20 K 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 7.3 6.0 1.1 5.2 0.5 0.2 0.2 0.1
LIABILITIES
Accounts Payable 0.5 0.6 1.0 0.3 3.98 K 9.68 K 5.83 K 832
Short Term Debt 36.7 K 0 28.2 K 0 0 0 0 0
Other Current Liabilities 3.6 4.4 1.6 6.66 K 6.05 K 24.2 K 1.82 K 50.5 K
Total Current Liabilities 4.1 5.0 2.6 0.4 13.4 K 44.6 K 7.64 K 65.8 K
Long Term Debt 16.4 K 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0
Total Liabilities 4.1 5.0 2.6 0.4 13.4 K 44.6 K 7.64 K 65.8 K
EQUITY
Common Stock 24.2 17.1 9.2 7.9 0.9 0.3 0.3 70 K
Retained Earnings (24.0) (18.8) (13.8) (4.4) (0.5) (0.3) (0.2) 6.67 K
Other Accumulative Comprehensive Income/Loss 21.2 K 15.4 K 0.6 1.3 0.1 0.1 0.1 0
Total Equity 3.1 1.4 (1.5) 4.8 0.5 0.1 0.2 63.3 K
Total Liabilities and Equity 7.3 6.0 1.1 5.2 0.5 0.2 0.2 0.1
SHARES OUTSTANDING
Common Shares Outstanding 4.3 2.0 0.4 0.3 0.2 0.1 0.1 0.1